Đang chuẩn bị liên kết để tải về tài liệu:
Predictors of response to viscosupplementation in patients with hip osteoarthritis: Results of a prospective, observational, multicentre, open-label, pilot study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

To identify predictive factors of response to viscosupplementation (VS) in patients with hip osteoarthritis (HOA). Methods: Prospective, multicentre, open-label trial, achieved in daily practice conditions. Patients with HOA were treated with a single intra-articular injection of a cross-linked hyaluronic acid combined with mannitol (HAnox-M-XL), using imaging guidance. |

TÀI LIỆU LIÊN QUAN

Báo cáo y học: "Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia"

Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension

The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: A prospective study in 393 patients

Báo cáo khoa học: "Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women"

Báo cáo y học: " Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa"

Báo cáo hóa học: "DNA polymeraseh protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy"
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.